PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsMAIA Biotechnology
MAIA Biotechnology(MAIA)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AngiomaxBivalirudin2019-07-252028-2039
Acute coronary syndrome
,
Unstable angina
BaclofenBaclofen2019-09-112037-2041
Multiple sclerosis
,
Spinal cord injuries
,
Spinal cord neoplasms
,
Hiccup
,
Neurogenic urinary bladder
,
Muscle spasticity
,
Cerebral palsy
,
Spinal cord ischemia
,
Trigeminal neuralgia
,
Huntington disease
,
Transverse myelitis
,
Spondylolysis
,
Intractable pain
BortezomibBortezomib2022-07-272032-2042
Multiple myeloma
,
Mantle-cell lymphoma
LevothyroxineLevothyroxine2018-12-212024-2039
Thyroid neoplasms,
Autoimmune thyroiditis,
Goiter,
Thyrotoxicosis,
Myxedema
SincalideSincalide2022-11-222038
—
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Bevifimod
carcinoma
,
non-small-cell lung carcinoma
Pcd
carcinoma
,
non-small-cell lung carcinoma
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use